Farrugia is recently the CEO of Mayo Hospital in Florida and a Mayo vp. He will be triumphant Dr. John Noseworthy, a neurologist who’s retiring on the finish of the 12 months after serving on the helm of the Rochester, Minn.-based not-for-profit well being device since 2009.
Noseworthy, who will paintings intently with Farrugia till he assumes the placement Jan. 1, 2019, known as him a visionary and servant chief who brings a wealth of enjoy as an innovator and an govt.
“In partnership with our body of workers throughout Mayo Hospital, and with a deep dedication to our values and project, he’s going to confirm Mayo Hospital’s place as the worldwide well being care chief for generations to return,” Noseworthy stated in a observation.
Leader amongst Farrugia’s tasks can be overseeing the Vacation spot Clinical Heart, a 20-year, $five.6 billion venture first proposed by means of Mayo in 2010. The state of Minnesota has dedicated $585 million into the venture, which used to be envisioned as a anchor for the rising Rochester inhabitants. The DMC goals to create greater than 30,000 new jobs and generate $270 million in new tax income for the town over the following 20 years.
In Farrugia’s present position, which he is held since January 2015, he leads greater than 6,400 body of workers contributors. Underneath his watch, Mayo’s Florida campus constructed a “vacation spot scientific development” to regard complicated cancers and supply neurologic and neurosurgical care. Mayo stated in a information free up that Farrugia’s tenure has noticed investments in folks, generation and growth. Truven Well being Analytics named Mayo’s Jacksonville campus some of the nation’s most sensible 100 educating hospitals this 12 months.
Farrugia represented Mayo on the Global Financial Discussion board in Davos, Switzerland previous this 12 months, a place Noseworthy had occupied at each and every of the former six annual meetings. Mayo spokeswoman Duska Anastasijevic stated that used to be simply the results of a scheduling struggle, but in addition that Farrugia has led Mayo’s world technique, given the well being device is organising its Florida campus as a vacation spot for world sufferers.
Mayo’s native land newspaper, the Rochester Put up-Bulletin, appropriately named Farrugia as one in every of 3 most probably contenders for the highest submit in March.
Previous to main Mayo’s Florida operations, Farrugia used to be director of Mayo’s Heart for Individualized Medication, which is tasked with bringing genomics into regimen medical care. He additionally co-founded Mayo’s Heart for Innovation.
“I’m humbled and proud to apply and construct upon this good fortune with the most productive body of workers on the earth,” Farrugia stated in a observation. “Whilst sea alternate continues to brush via well being care, I sit up for harnessing innovation, an indicator of Mayo Hospital, to turn out to be well being deal with the good thing about sufferers far and wide.”
Farrugia has been a Mayo doctor for 30 years. The device if truth be told has bylines that require new management to return from inside and for that chief to be a health care provider. Farrugia holds posts in gastroenterology, hepatology, inner medication, body structure and biomedical engineering. He is a professor of drugs and body structure and a college member in biomedical engineering at Mayo’s Graduate College of Biomedical Sciences.
He earned his undergraduate level at St. Aloysius Faculty and his scientific level from the College of Malta Clinical College, each situated in his local Malta, an island nation within the Mediterranean Sea. He’s the primary foreign-born Mayo chief after William Worrall Mayo, the daddy of the Mayo brothers who hailed from England.
Farrugia, a member of Mayo’s Board of Trustees and its Board of Governors, co-authored a guide highlighting the desire for alternate in healthcare supply. He has revealed greater than 250 articles on genomics and the remedy of gastrointestinal motility, in keeping with a Mayo information free up.
“Dr. Farrugia brings an outstanding intensity of enjoy to this position,” Samuel Di Piazza, chair of Mayo’s Board of Trustees, stated in a observation. “A prolific investigator and inventor, and an completed govt, he has been at the forefront of innovation around the breadth of Mayo’s medical and analysis project.”
Mayo stated Farrugia’s variety concludes a radical seek procedure led by means of a committee that integrated contributors of its Board of Governors and Board of Trustees, the 31-member workforce of exterior trade and idea leaders and Mayo physicians and directors that unanimously voted to call Farrugia CEO. The committee collected enter from senior leaders, physicians and balloting body of workers.
Anastasijevic may just no longer right away percentage what Farrugia’s wage can be as CEO. Noseworthy made $2.eight million in general repayment in 2016, together with $2.2 million in base pay.
Noseworthy introduced he used to be leaving in February. All over his tenure, he oversaw the implementation of a brand new digital well being report device on the well being device’s primary campus that used to be a part of a $1.five billion Epic set up. The famend analysis establishment completed the 12 months with $707 million in source of revenue from operations on income of $12 billion, up from a $475 million source of revenue from operations final 12 months on income of $11 billion in 2016.
Mayo invested $714 million in capital tasks together with implementation of a unmarried, built-in digital well being report and income cycle control device. The ones capital investments come with expansions at Mayo Hospital’s Florida campus, its Rochester, Minn. amenities in addition to bolstering its most cancers heart at Franciscan Healthcare in Los angeles Crosse, Wis.
The group confronted grievance final 12 months after a speech from Noseworthy surfaced suggesting prioritizing the commercially insured over Medicaid or Medicare beneficiaries. Mayo additionally persevered backlash for reducing services and products at its Albert Lea sanatorium.
Tale in Development